220 related articles for article (PubMed ID: 19361597)
1. Prospective evaluation of fetuses with autoimmune-associated congenital heart block followed in the PR Interval and Dexamethasone Evaluation (PRIDE) Study.
Friedman DM; Kim MY; Copel JA; Llanos C; Davis C; Buyon JP
Am J Cardiol; 2009 Apr; 103(8):1102-6. PubMed ID: 19361597
[TBL] [Abstract][Full Text] [Related]
2. Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus.
Saleeb S; Copel J; Friedman D; Buyon JP
Arthritis Rheum; 1999 Nov; 42(11):2335-45. PubMed ID: 10555029
[TBL] [Abstract][Full Text] [Related]
3. Spectrum and progression of conduction abnormalities in infants born to mothers with anti-SSA/Ro-SSB/La antibodies.
Askanase AD; Friedman DM; Copel J; Dische MR; Dubin A; Starc TJ; Katholi MC; Buyon JP
Lupus; 2002; 11(3):145-51. PubMed ID: 11999879
[TBL] [Abstract][Full Text] [Related]
4. Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR Interval and Dexamethasone Evaluation (PRIDE) prospective study.
Friedman DM; Kim MY; Copel JA; Davis C; Phoon CK; Glickstein JS; Buyon JP;
Circulation; 2008 Jan; 117(4):485-93. PubMed ID: 18195175
[TBL] [Abstract][Full Text] [Related]
5. Fetal treatment of congenital heart block ascribed to anti-SSA antibody: case reports with observation of cardiohemodynamics and review of the literature.
Yamada H; Kato EH; Ebina Y; Moriwaki M; Yamamoto R; Furuta I; Fujimoto S
Am J Reprod Immunol; 1999 Oct; 42(4):226-32. PubMed ID: 10580604
[TBL] [Abstract][Full Text] [Related]
6. Normal neuropsychological development in children with congenital complete heart block who may or may not be exposed to high-dose dexamethasone in utero.
Brucato A; Astori MG; Cimaz R; Villa P; Li Destri M; Chimini L; Vaccari R; Muscarà M; Motta M; Tincani A; Neri F; Martinelli S
Ann Rheum Dis; 2006 Nov; 65(11):1422-6. PubMed ID: 16504990
[TBL] [Abstract][Full Text] [Related]
7. First-degree heart block in the fetus of an anti-SSA/Ro-positive mother: reversal after a short course of dexamethasone treatment.
Vesel S; Mazić U; Blejec T; Podnar T
Arthritis Rheum; 2004 Jul; 50(7):2223-6. PubMed ID: 15248221
[TBL] [Abstract][Full Text] [Related]
8. Outcome and growth of infants fetally exposed to heart block-associated maternal anti-Ro52/SSA autoantibodies.
Skog A; Wahren-Herlenius M; Sundström B; Bremme K; Sonesson SE
Pediatrics; 2008 Apr; 121(4):e803-9. PubMed ID: 18381509
[TBL] [Abstract][Full Text] [Related]
9. Neonatal lupus: bedside to bench and back.
Buyon JP
Scand J Rheumatol; 1996; 25(5):271-6. PubMed ID: 8921918
[TBL] [Abstract][Full Text] [Related]
10. Congenital heart block in neonatal lupus: the pediatric cardiologist's perspective.
Friedman DM; Rupel A; Glickstein J; Buyon JP
Indian J Pediatr; 2002 Jun; 69(6):517-22. PubMed ID: 12139139
[TBL] [Abstract][Full Text] [Related]
11. Signs of first-degree heart block occur in one-third of fetuses of pregnant women with anti-SSA/Ro 52-kd antibodies.
Sonesson SE; Salomonsson S; Jacobsson LA; Bremme K; Wahren-Herlenius M
Arthritis Rheum; 2004 Apr; 50(4):1253-61. PubMed ID: 15077309
[TBL] [Abstract][Full Text] [Related]
12. Maternal steroid therapy for fetuses with second-degree immune-mediated congenital atrioventricular block: a systematic review and meta-analysis.
Ciardulli A; D'Antonio F; Magro-Malosso ER; Manzoli L; Anisman P; Saccone G; Berghella V
Acta Obstet Gynecol Scand; 2018 Jul; 97(7):787-794. PubMed ID: 29512819
[TBL] [Abstract][Full Text] [Related]
13. Congenital heart block related to maternal autoantibodies: descriptive analysis of a series of 18 cases from a single center.
Doti PI; Escoda O; Cesar-Díaz S; Palasti S; Teixidó I; Sarquella-Brugada G; Gómez O; Martínez JM; Espinosa G
Clin Rheumatol; 2016 Feb; 35(2):351-6. PubMed ID: 26791874
[TBL] [Abstract][Full Text] [Related]
14. Fetal congenital complete heart block: prophylaxis with intravenous gammaglobulin and treatment with dexamethasone.
Wong JP; Kwek KY; Tan JY; Yeo GS
Aust N Z J Obstet Gynaecol; 2001 Aug; 41(3):339-41. PubMed ID: 11592556
[TBL] [Abstract][Full Text] [Related]
15. Conduction system disease in fetuses evaluated for irregular cardiac rhythm.
Cuneo BF; Strasburger JF; Wakai RT; Ovadia M
Fetal Diagn Ther; 2006; 21(3):307-13. PubMed ID: 16601344
[TBL] [Abstract][Full Text] [Related]
16. [Congenital heart block associated with maternal anti SSA/SSB antibodies :a report of four cases].
Ayed K; Gorgi Y; Sfar I; Khrouf M
Pathol Biol (Paris); 2004 Apr; 52(3):138-47. PubMed ID: 15063933
[TBL] [Abstract][Full Text] [Related]
17. Prevention of complete heart block in children of mothers with anti-SSA/Ro and anti-SSB/La autoantibodies: detection and treatment of first-degree atrioventricular block.
Mevorach D; Elchalal U; Rein AJ
Curr Opin Rheumatol; 2009 Sep; 21(5):478-82. PubMed ID: 19584727
[TBL] [Abstract][Full Text] [Related]
18. Obstetric and perinatal outcome in anti-Ro/SSA-positive pregnant women: a prospective cohort study.
Martínez-Sánchez N; Pérez-Pinto S; Robles-Marhuenda Á; Arnalich-Fernández F; Martín Cameán M; Hueso Zalvide E; Bartha JL
Immunol Res; 2017 Apr; 65(2):487-494. PubMed ID: 28138914
[TBL] [Abstract][Full Text] [Related]
19. Benefits of fetal echocardiographic surveillance in pregnancies at risk of congenital heart block: single-center study of 212 anti-Ro52-positive pregnancies.
Sonesson SE; Ambrosi A; Wahren-Herlenius M
Ultrasound Obstet Gynecol; 2019 Jul; 54(1):87-95. PubMed ID: 30620419
[TBL] [Abstract][Full Text] [Related]
20. Failure of intravenous immunoglobulin to prevent congenital heart block: Findings of a multicenter, prospective, observational study.
Pisoni CN; Brucato A; Ruffatti A; Espinosa G; Cervera R; Belmonte-Serrano M; Sánchez-Román J; García-Hernández FG; Tincani A; Bertero MT; Doria A; Hughes GR; Khamashta MA
Arthritis Rheum; 2010 Apr; 62(4):1147-52. PubMed ID: 20131278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
